Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.

Le Thiec, Maelle; Testard, Aude; Ferrer, Ludovic; Guillerminet, Camille; Morel, Olivier; Maucherat, Bruno; Rusu, Daniela; Girault, Sylvie; Lacombe, Marie; Hamidou, Hadji; Meyer, Véronique Guérin; Rio, Emmanuel; Hiret, Sandrine; Kraeber-Bodéré, Françoise; Campion, Loïc; Rousseau, Caroline.

Afiliação

Le Thiec M; Nuclear Medicine Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Testard A; Nuclear Medicine Unit, ICO Cancer Center, 49055 Angers, France.
Ferrer L; Medical Physics Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Guillerminet C; CRCINA, University of Nantes and Angers, INSERM UMR1232, CNRS-ERL6001, 49055 Angers, France.
Morel O; Medical Physics Unit, ICO Cancer Center, 49055 Angers, France.
Maucherat B; Nuclear Medicine Unit, ICO Cancer Center, 49055 Angers, France.
Rusu D; Nuclear Medicine Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Girault S; Nuclear Medicine Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Lacombe M; Nuclear Medicine Unit, ICO Cancer Center, 49055 Angers, France.
Hamidou H; Nuclear Medicine Unit, ICO Cancer Center, 49055 Angers, France.
Meyer VG; Radiation Oncology Unit, ICO Cancer Center, 49055 Angers, France.
Rio E; Medical Oncology Unit, ICO Cancer Center, 49055 Angers, France.
Hiret S; Radiation Oncology Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Kraeber-Bodéré F; Medical Oncology Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Campion L; Nuclear Medicine Unit, ICO Cancer Center, 44805 Saint Herblain, France.
Rousseau C; CRCINA, University of Nantes and Angers, INSERM UMR1232, CNRS-ERL6001, 49055 Angers, France.